Rhinitis/rhinorrhea (Intranasal Products)

Budesonide With Saline Solution Helpful for Rhinosinusitis

July 09, 2018

The researchers found that the budesonide group had a mean score on the Sino-Nasal Outcome Test (SNOT-22) that was 7 points better (95% confidence interval, −2 to 16) than the control group.

Pediatric Chronic Rhinosinusitis: Treatment Options to Consider

By June 20, 2018

Because determining an appropriate treatment plan for a patient depends on the subtype of the disease, it is imperative for providers to know and understand the underlying mechanisms of CRS as well as the components included in a medical evaluation of a patient.

Recall: Rhinitis Treatment May Contain Small Glass Particles

By May 31, 2018

Fluticasone Propionate Nasal Spray is a corticosteroid indicated for the management of the nasal symptoms of perennial nonallergic rhinitis in adults and pediatric patients aged 4 years and older.

Impact of Allergic Rhinitis, Rhinoconjunctivitis on Adolescents "Far-Reaching"

By May 21, 2018

A total of 27 articles were identified. Of these, 6 evaluated symptoms, 9 assessed QOL, 5 studied daily activities, 3 evaluated emotional aspects, 6 assessed sleep, 7 studied education, and 2 evaluated treatment burden.

Most Patients Select Suboptimal Medications for Allergic Rhinitis

April 03, 2018

The researchers found that just under two-thirds of customers (63.2%) had a doctor's diagnosis for the symptoms for which they were selecting treatment. The majority of participants (70%) self-selected their medications.

Sinuva Sinus Implant Launched to Treat Recurrent Nasal Polyps

By April 02, 2018

Sinuva can be implanted during a routine physician visit under local or topical anesthesia.

Antibiotic Treatment Duration for Sinusitis Often Exceeds Recommendations

By March 28, 2018

Duration of outpatient antibiotic therapy for acute sinusitis often exceeds guidelines recommendations.

Odactra Available for House Dust Mite-Induced Allergic Rhinitis

By January 10, 2018

Odactra is an allergen extract indicated as immunotherapy for house dust mite (HDM)-induced allergic rhinitis.

New Treatment Option for Recurrent Nasal Polyps Gets FDA Approval

By December 11, 2017

The Sinuva Sinus Implant is a corticosteroid-eluting (mometasone furoate) implant indicated for the treatment of nasal polyps.

FlutiCare Nasal Spray Now Available OTC to Relieve Allergy Symptoms

By November 14, 2017

FlutiCare will be available OTC with the same prescription strength and same delivery method as Flonase and ClariSpray.

Seasonal Allergic Rhinitis Treatment Guidelines Updated

By November 07, 2017

The guidelines focus on three key clinical statements.

HydraSense Nasal Care Line Available for Infants and Children

By November 01, 2017

hydraSense hydrates and soothes dry and uncomfortable nasal passages.

Xhance Nasal Spray Approved to Treat Nasal Polyps

By September 20, 2017

Xhance was evaluated in five trials enrolling >1,500 adults.

Obstructive Sleep Apnea and Elevated Blood Coagulability: Is There a Link?

August 18, 2017

Significant differences were identified in PT seconds for the control group versus the moderate and severe OSA groups (mean, 11.26 versus 10.74 and 10.67, respectively).

Capsaicin Nasal Spray Evaluated in Patients with Mixed Rhinitis

July 20, 2017

"In conclusion, the capsaicin nasal spray is effective in a broader group of IR than the purely selected ones described before," the authors wrote.

New Supplement Available for Relief of Allergy Symptoms

By May 24, 2017

In aclinical trial, AllerVarx decreased total symptom scores by ~70% and decreased the use of anti-allergic meds by ~73%.

Sinuva Implant for Chronic Sinusitis to Be FDA Reviewed

By May 23, 2017

The Sinuva implant releases mometasone furoate to the ethmoid sinus lining and is intended to treat chronic sinusitis patients who have recurrent sinus obstruction.

EAACI: Position Paper on Non-Allergic Rhinitis Management

May 11, 2017

The authors note that diagnosis of NAR is based on a detailed medical history and exclusion of clinically relevant sensitization to airborne allergens, and exclusion of clinical signs of rhinosinusitis.

Uncontrolled Allergic Rhinitis Impacts Work Productivity

April 14, 2017

Symptoms of allergic rhinitis controlled in about 60 percent of days according to mobile phone app

Serum Periostin Investigated as Rhinosinusitis Identifier

March 21, 2017

Receiver operating curve analyses showed moderate and high diagnostic accuracy for detecting chronic rhinosinusitis and chronic rhinosinusitis with nasal polyps, respectively.

Odactra Approved for House Dust Mite Allergies

By March 02, 2017

Odactra provides patients an alternative treatment to allergy shots.

Steroid-Releasing Implant Improves Surgical Outcomes in Chronic Sinusitis

By February 24, 2017

Propel Contour features an hourglass design and is specifically designed to conform to the sinus ostia.

Flonase Sensimist Available OTC for Allergy Relief

By February 08, 2017

GSK Consumer Healthcare announced the availability of Flonase Sensimist Allergy Relief (fluticasone furoate), an over-the-counter (OTC) treatment for symptoms associated with seasonal and perennial allergies for patients aged ≥12 years.

Cell Expression May ID Severity of Chronic Rhinosinusitis

February 02, 2017

Programmed cell death 1 (PD-1) expression is associated with chronic rhinosinusitis with nasal polyps (CRSwNP) disease severity, according to a study published online in Allergy.

Verapamil May Be Effective in Severe Chronic Rhinosinusitis

By January 23, 2017

Verapamil, a calcium channel blocker, has shown significant efficacy in alleviating symptoms of patients with chronic rhinosinusitis (CRS) with nasal polyps.

Treatments for Pollen-Related Allergic Rhinoconjunctivitis Compared

October 11, 2016

Findings based on number of symptom-free days for daily versus as-needed treatment

Intranasal Therapies Evaluated for Reducing HHT-Related Epistaxis

September 07, 2016

Saline as good as medications for hereditary hemorrhagic telangiectasia, researchers find

Beneficial Therapy Underutilized in Chronic Rhinosinusitis

August 29, 2016

Rate of intranasal steroid spray utilization 20.1 per 100 patients; geographic variation in rate

FDA Approves New Rx-to-OTC Switch for Allergy Nasal Spray

By August 03, 2016

The OTC treatment is for symptoms associated with seasonal and perennial allergies in patients aged ≥2 years.

Nasal Irrigation, Steam Inhalation Evaluated in Chronic Sinusitis

July 19, 2016

Steam inhalation may ease headaches, but no significant improvement in RSDI scores